Continuous Glucose Monitoring (CGM): Technologies and Global Markets

December 16, 2022

New York, Dec. 16, 2022 (GLOBE NEWSWIRE) -- announces the release of the report "Continuous Glucose Monitoring (CGM): Technologies and Global Markets" - The test strip market numbers refer to all types of test strips with SMBG, and not just test strips as used by CGM users.CGM users also use test strips, but theoretically only for calibrating their CGM devices.The report also includes discussions of the market opportunities, patent scenario, market projections and market shares, competitive landscape, and the key company profiles. The report would also cover the COVID-19 impact on the CGM market.Report Includes:- 27 data tables and 28 additional tables- A detailed overview and an up-to-date analysis of the global markets for continuous glucose monitoring (CGM) devices and technologies- Analyses of the global market trends, with historic market revenue (sales figures) for 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027- Highlights of market opportunities for this innovation-driven continuous glucose monitoring devices market, and the major regions and countries involved in market developments- Estimation of the actual market size and revenue forecast for CGM devices in USD million values, and corresponding market share analysis by technology type, end-user settings, type of diabetes, user age group, and region- Country specific data and market value analysis for the United States, Canada, Germany, U.K., France, Italy, Japan, China, South Korea, etc.- Reassessment of the critical issues surrounding CGM transmitters/receivers, self-monitoring blood glucose (SMBG) equipment and test strips, and durable insulin pumps; their recent technological advancements, geographic trends, market dynamics, and adoption trends- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, financial performance, and segmental revenues- Review of the key patent grants and patent applications within select CGM technologies- Company profiles of major players within the industry, including Abbott Laboratories, F. Hoffmann-La Roche, Medtronic PLC, Novo Nordisk, and Sanofi S.A.Summary:The global market for continuous glucose monitoring (CGM) devices was valued at $REDACTED in 2021.The market is forecast to grow at a compound annual growth rate (CAGR) of REDACTED% to reach approximately $REDACTED by 2027.In this report, the global market is segmented by technology type, user’s age, disease type, end-user settings, and region.Reasons for Doing This Study:This study provided detailed information regarding developments in continuous glucose monitoring.The incidence of Type 2 diabetes continues to increase in developed and developing countries, driven by the rise in obesity.Continuous glucose monitoring (CGM) is designed to provide a more accurate way to monitor blood glucose levels, allowing diabetic patients to regulate blood glucose better, decrease the risk of diabetes-related damage to their bodies and ultimately improve their health and decrease healthcare costs.This BCC Research market research report will increase the awareness of current and developing technologies affecting continuous glucose monitoring devices and markets.Read the full report: ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________

© 2024